Background In 2024, the UK National Institute of Health and Care Excellence (NICE) recommended TriageHF alerts as an option ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis on ALT stock.

Looking at the calendar year of 2025 — including multiplatform linear and streaming ratings — ABC's "High Potential" and CBS' ...

I rely on data for clarity and risk transparency, but instinct shapes how I interpret it. My approach combines analytical ...

Michael Wang, MD, professor at The University of Texas MD Anderson Cancer Center, details the rationale for a long-term ...

As one of the battle captains assigned to the 101st Airborne Division (Air Assault), I was first struck by the amount of chat ...

Nicholas Miller, policy associate at the National Conference of State Legislatures, explains how states are leaning into some ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

The latest figures from the Office for National Statistics (ONS) show the household savings ratio – how much households save ...

Patients in the ratutrelvir arm received ratutrelvir 600 mg orally once daily for 10 days, while patients in the comparator ...

A popular directory of pension advice professionals has closed, leaving those seeking help with their retirement unsure of ...

November jobs growth surprised to the upside at 64,000, with private payrolls at 69,000. Learn more about BLS report here.